Schering

FDA OKs Abilify for autism-linked irritability

PRINCETON, N.J. - The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday.

powered by

This Baby Is a Nice Addition (at Motley Fool)

Today, the drugmaker received a positive opinion from the EU's Committee for Medicinal Products for Human Use (CHMP) for its fertility treatment Elonva. The drug works just as well at helping women get pregnant as its currently...

powered by

Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) / First in the Class...

WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck&Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA®...

powered by

4-Star Stocks Poised to Pop: Merck (at Motley Fool)

With that in mind, let's take a closer look at Merck's business and see what CAPS investors are saying about the stock right now. Merck facts Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS. On CAPS,...

powered by

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at...

powered by

Effective Use of Asthma Inhalers

Information Patients Need Concerning Drugs Used to Treat Asthma Treatment of asthma is best done with a multifaceted approach, one that avoids or minimizes toxic side effects. Rescue Inhalers Treat Asthma Attacks Recent laws...

powered by

AHA: Obesity and Smoking Major Risk Factors for VTE (CME/CE)

Explain to interested patients that this study showed that smoking and excess weight are the primary risk factors for venous thrombotic events. Overweight smokers have the greatest risk of a venous thrombotic event, according...

powered by

Moody's Gives Negative View On Pharma Credit

Moody's: Credit Ratings For Drugmakers Could Be Hurt As Industry Copes With Expiring Patents (AP) NEW YORK (AP) - Moody's Investors Service issued a negative opinion on the pharmaceutical industry Thursday, saying drugmaker...

powered by

AHA: Low Bleeding Rates Observed in Dabigitran Dose-Ranging Trial (CME/CE)

ORLANDO (MedPage Today) -- The oral anti-coagulant dabigatran did not appear to markedly increase major bleeding rates among post-MI patients who were already being treated with aspirin and clopidogrel (Plavix), researchers...

powered by

Schering-Plough, Merck Settle $41.5 Million Class Action Lawsuit

histories. The United States District Court for the District of New Jersey has recently given preliminary approval to a settlement in a class action lawsuit regarding the prescription drugs Zetia and Vytorin. The lawsuit claims...

powered by
1 2 3 4 5 next »